Evidence map›Paper›PMID 36824731›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Genomic landscape of virus-associated cancers.

Karen Gomez, Gianluca Schiavoni, Yoonhee Nam, Jean-Baptiste Reynier, Cole Khamnei, Michael Aitken, Giuseppe Palmieri, Antonio Cossu, Arnold Levine, Carel van Noesel and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Karen Gomez
Gianluca Schiavoni
Yoonhee Nam
Jean-Baptiste Reynier
Cole Khamnei
Michael Aitken
Giuseppe Palmieri
Antonio Cossu
Arnold Levine
Carel van Noesel
Brunangelo Falini
Laura Pasqualucci
Enrico Tiacci
Columbia University · USUniversity of Perugia · ITUniversity of Sassari · ITAmsterdam University Medical Centers · NLCancer Genetics (United States) · USInstitute for Advanced Study · US

Funding

Towards a quantitative understanding of tumor evolutionR35CA253126 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Raul Rabadan · 2021 to 2026
$5.6M
NCI NIH HHS R35 CA253126
6 · The paper itself

Abstract

It has been estimated that 15%-20% of human cancers are attributable to infections, mostly by carcinogenic viruses. The incidence varies worldwide, with a majority affecting developing countries. Here, we present a comparative analysis of virus-positive and virus-negative tumors in nine cancers linked to five viruses. We find that virus-positive tumors occur more frequently in males and show geographical disparities in incidence. Genomic analysis of 1,658 tumors reveals virus-positive tumors exhibit distinct mutation signatures and driver gene mutations and possess a lower somatic mutation burden compared to virus-negative tumors of the same cancer type. For example, compared to the respective virus-negative counterparts, virus-positive cases across different cancer histologies had less often mutations of

Identifiers

PMID36824731
PMCPMC9949223
OpenAlexW4321240698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.